FCGR2A and autoimmune bullous skin disease: Initial ex vivo experiments demonstrated that luteolin inhibited the FcγR-dependent production of ROS by leukocytes and partly the pemphigoid autoantibody-induced granulocyte-dependent dermal-epidermal separation of skin sections.